Financial Impact of Two Different Ways of Evaluating Early Virological Response to Peginterferon- -2b Plus Ribavirin Therapy in Treatment-Naive Patients with Chronic Hepatitis C Virus Genotype 1

Author: Buti Maria  

Publisher: Adis International

ISSN: 1170-7690

Source: PharmacoEconomics, Vol.23, Iss.10, 2005-01, pp. : 1043-1055

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content